Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

13.49
-0.4600-3.30%
Post-market: 13.500.0100+0.07%19:59 EDT
Volume:4.83M
Turnover:65.62M
Market Cap:2.72B
PE:-63.54
High:13.83
Open:13.66
Low:13.37
Close:13.95
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:0.86
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:19.79
PE(LYR):-54.76

Loading ...

Movement Alert|SELLAS Life Sciences Group Rises 8.67% in Regular Trading, Trading at $14.47

Market Focus
·
Jul 02

Movement Alert|SELLAS Life Sciences Group Declines 9.55% in Regular Trading, Trading at $13.34

Market Focus
·
Jul 01

Sellas Life Sciences falls -11.0%

TIPRANKS
·
Jul 01

Sellas Life Sciences rises 16.8%

TIPRANKS
·
Jun 29

Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; SELLAS Life Sciences, Strategy to Open Higher

MT Newswires Live
·
Jun 29

Sellas Revises Change-of-control Severance Terms for CFO Burns, Development Chief Cicic

Reuters
·
Jun 25

SELLAS Life Sciences Group (SLS) Looks Pricey Following Phase 3 REGAL Trial Progress

Simply Wall St.
·
Jun 25

Solstice Minerals Limited (SLS) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Jun 19

Sellas Life Sciences holds annual shareholder meeting, stockholders approve equity plan share increase

Reuters
·
Jun 19

Sims Fiscal 2026 Outlook Beats Consensus on US Scrap Conditions, Jefferies Says

MT Newswires Live
·
Jun 18

Former Sims Bear Gets More Confidence in SLS -- Market Talk

Dow Jones
·
Jun 18

SELLAS Life Sciences Group (SLS) Stock Looks Fully Valued After $154.6 Million Shelf Filing

Simply Wall St.
·
Jun 17

Sims Rally Powered by SLS Earnings, Solid Metals Markets -- Market Talk

Dow Jones
·
Jun 10

A Look At SELLAS Life Sciences Group (SLS) Valuation After Arbitration And Phase 3 Regal Trial Hopes

Simply Wall St.
·
Jun 09

Sellas Life Sciences gets about $28.7 million from warrant exercises in April-May 2026

Reuters
·
Jun 02

Why SELLAS Life Sciences Group (SLS) Is Up 19.7% After Cramer Endorsement And REGAL Trial Focus

Simply Wall St.
·
Jun 01

Former Sims Bear Questions SLS Earnings Outlook -- Market Talk

Dow Jones
·
Jun 01

Assessing SELLAS Life Sciences Group (SLS) Valuation After Strong Multi-Year Returns And A Sharp One-Day Share Price Drop

Simply Wall St.
·
May 22

SELLAS Life Sciences Group Down Nearly 19%, on Pace for Largest Percent Decrease Since March 2024 -- Data Talk

Dow Jones
·
May 22

SELLAS Life Sciences (SLS) Nears Pivotal AML Data as Cash, Pipeline and ATM Plan Reframe Its Story

Simply Wall St.
·
May 18